{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:12:49Z","timestamp":1778649169231,"version":"3.51.4"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32 AI007140-46"],"award-info":[{"award-number":["T32 AI007140-46"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA057920"],"award-info":[{"award-number":["T32DA057920"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11904-025-00758-9","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T08:09:48Z","timestamp":1760342988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Digital Interventions for Stimulant Use Among People Living with HIV: A Narrative Review"],"prefix":"10.1007","volume":"22","author":[{"given":"Michael P.","family":"Barry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis A.","family":"Slaughter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann E.","family":"Richey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Gleason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicky","family":"Cotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitlin A.","family":"Zinsli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"issue":"1","key":"758_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/QAI.0000000000001643","volume":"78","author":"JA Fulcher","year":"2018","unstructured":"Fulcher JA, Shoptaw S, Makgoeng SB, et al. Brief report: recent methamphetamine use is associated with increased rectal mucosal inflammatory cytokines, regardless of HIV-1 serostatus. JAIDS J Acquir Immune Defic Syndr. 2018;78(1):119\u201323. https:\/\/doi.org\/10.1097\/QAI.0000000000001643.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"1","key":"758_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-021-00703-4","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu Y, Meng FZ, Wang X, et al. Methamphetamine facilitates HIV infection of primary human monocytes through inhibiting cellular viral restriction factors. Cell Biosci. 2021;11(1):194. https:\/\/doi.org\/10.1186\/s13578-021-00703-4.","journal-title":"Cell Biosci"},{"issue":"9","key":"758_CR3","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1089\/aid.2011.0329","volume":"28","author":"RK Doshi","year":"2012","unstructured":"Doshi RK, Vogenthaler NS, Lewis S, Rodriguez A, Metsch L, Rio Cdel. Correlates of antiretroviral utilization among hospitalized HIV-infected crack cocaine users. AIDS Res Hum Retroviruses. 2012;28(9):1007\u201314. https:\/\/doi.org\/10.1089\/aid.2011.0329.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"758_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108135","volume":"213","author":"JA Cepeda","year":"2020","unstructured":"Cepeda JA, Vickerman P, Bruneau J, et al. Estimating the contribution of stimulant injection to HIV and HCV epidemics among people who inject drugs and implications for harm reduction: a modeling analysis. Drug Alcohol Depend. 2020;213:108135. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108135.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"758_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/QAI.0000000000002461","volume":"85","author":"C Grov","year":"2020","unstructured":"Grov C, Westmoreland D, Morrison C, Carrico AW, Nash D. The crisis we are not talking about: one-in-three annual HIV seroconversions among sexual and gender minorities were persistent methamphetamine users. JAIDS J Acquir Immune Defic Syndr. 2020;85(3):272\u20139. https:\/\/doi.org\/10.1097\/QAI.0000000000002461.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"758_CR6","unstructured":"NIDA. What is the scope of methamphetamine use in the United States? 2024. Accessed February 10, 2024. https:\/\/nida.nih.gov\/publications\/research-reports\/methamphetamine\/what-scope-methamphetamine-misuse-in-united-states"},{"issue":"1","key":"758_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nyas.14688","volume":"1508","author":"CM Jones","year":"2022","unstructured":"Jones CM, Houry D, Han B, Baldwin G, Vivolo-Kantor A, Compton WM. Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction. Ann N Y Acad Sci. 2022;1508(1):3\u201322. https:\/\/doi.org\/10.1111\/nyas.14688.","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"758_CR8","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1001\/jamapsychiatry.2021.2588","volume":"78","author":"B Han","year":"2021","unstructured":"Han B, Compton WM, Jones CM, Einstein EB, Volkow ND. Methamphetamine use, methamphetamine use disorder, and associated overdose deaths among US adults. JAMA Psychiatr. 2021;78(12):1329. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.2588.","journal-title":"JAMA Psychiatr"},{"key":"758_CR9","unstructured":"NIHCM Foundation. Stimulant deaths on the rise, compounded by rise in synthetic opioids. Published Online May 13, 2021. https:\/\/nihcm.org\/publications\/stimulant-deaths-on-the-rise-compounded-by-rise-in-synthetic-opioids"},{"issue":"1\u20132","key":"758_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jneuroim.2003.10.010","volume":"147","author":"DP Tashkin","year":"2004","unstructured":"Tashkin DP. Evidence implicating cocaine as a possible risk factor for HIV infection. J Neuroimmunol. 2004;147(1\u20132):26\u20137. https:\/\/doi.org\/10.1016\/j.jneuroim.2003.10.010.","journal-title":"J Neuroimmunol"},{"key":"758_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00136","volume":"11","author":"KS Lawson","year":"2020","unstructured":"Lawson KS, Prasad A, Groopman JE. Methamphetamine enhances HIV-1 replication in CD4\u2009+\u2009t-cells via a novel IL-1\u03b2 auto-regulatory loop. Front Immunol. 2020;11:136. https:\/\/doi.org\/10.3389\/fimmu.2020.00136.","journal-title":"Front Immunol"},{"issue":"5","key":"758_CR12","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2174\/1570162X14666160324124736","volume":"14","author":"M Tyagi","year":"2016","unstructured":"Tyagi M, Bukrinsky M, Simon L. Mechanisms of HIV transcriptional regulation by drugs of abuse. CHR. 2016;14(5):442\u201354. https:\/\/doi.org\/10.2174\/1570162X14666160324124736.","journal-title":"CHR"},{"issue":"3","key":"758_CR13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11481-015-9604-2","volume":"10","author":"RC Passaro","year":"2015","unstructured":"Passaro RC, Pandhare J, Qian HZ, Dash C. The complex interaction between methamphetamine abuse and HIV-1 pathogenesis. J Neuroimmune Pharmacol. 2015;10(3):477\u201386. https:\/\/doi.org\/10.1007\/s11481-015-9604-2.","journal-title":"J Neuroimmune Pharmacol"},{"key":"758_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/121352","volume":"2013","author":"KJ Horvath","year":"2013","unstructured":"Horvath KJ, Carrico AW, Simoni J, Boyer EW, Amico KR, Petroll AE. Engagement in HIV medical care and technology use among stimulant-using and nonstimulant-using men who have sex with men. AIDS Res Treat. 2013;2013:1\u201311. https:\/\/doi.org\/10.1155\/2013\/121352.","journal-title":"AIDS Res Treat"},{"key":"758_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.drugalcdep.2018.07.038","volume":"192","author":"H Jin","year":"2018","unstructured":"Jin H, Ogunbajo A, Mimiaga MJ, et al. Over the influence: the HIV care continuum among methamphetamine-using men who have sex with men. Drug Alcohol Depend. 2018;192:125\u20138. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.07.038.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"758_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-016-3325-1","volume":"16","author":"AW Carrico","year":"2016","unstructured":"Carrico AW, Jain J, Discepola MV, et al. A community-engaged randomized controlled trial of an integrative intervention with HIV-positive, methamphetamine-using men who have sex with men. BMC Public Health. 2016;16(1):673. https:\/\/doi.org\/10.1186\/s12889-016-3325-1.","journal-title":"BMC Public Health"},{"issue":"1","key":"758_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/QAI.0000000000001867","volume":"80","author":"AW Carrico","year":"2019","unstructured":"Carrico AW, Hunt PW, Neilands TB, et al. Stimulant use and viral suppression in the era of universal antiretroviral therapy. JAIDS J Acquir Immune Defic Syndr. 2019;80(1):89\u201393. https:\/\/doi.org\/10.1097\/QAI.0000000000001867.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"Supplement 1","key":"758_CR18","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1097\/QAI.0b013e3181f9c10b","volume":"55","author":"DS Metzger","year":"2010","unstructured":"Metzger DS, Woody GE, O\u2019Brien CP. Drug treatment as HIV prevention: A research update. JAIDS J Acquir Immune Defic Syndr. 2010;55(Supplement 1):S32\u20136. https:\/\/doi.org\/10.1097\/QAI.0b013e3181f9c10b.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"9","key":"758_CR19","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2019.1343","volume":"321","author":"AS Fauci","year":"2019","unstructured":"Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the united states. JAMA. 2019;321(9):844. https:\/\/doi.org\/10.1001\/jama.2019.1343.","journal-title":"JAMA"},{"issue":"2","key":"758_CR20","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cbpra.2017.08.003","volume":"25","author":"W G\u00f3mez","year":"2018","unstructured":"G\u00f3mez W, Olem D, Andrews R, et al. Optimizing contingency management with Methamphetamine-Using men who have sex with men. Cogn Behav Pract. 2018;25(2):286\u201395. https:\/\/doi.org\/10.1016\/j.cbpra.2017.08.003.","journal-title":"Cogn Behav Pract"},{"issue":"11","key":"758_CR21","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1176\/ajp.2006.163.11.1993","volume":"163","author":"JM Roll","year":"2006","unstructured":"Roll JM, Petry NM, Stitzer ML, et al. Contingency management for the treatment of methamphetamine use disorders. AJP. 2006;163(11):1993\u20139. https:\/\/doi.org\/10.1176\/ajp.2006.163.11.1993.","journal-title":"AJP"},{"issue":"1","key":"758_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-10-774","volume":"10","author":"TW Menza","year":"2010","unstructured":"Menza TW, Jameson DR, Hughes JP, Colfax GN, Shoptaw S, Golden MR. Contingency management to reduce methamphetamine use and sexual risk among men who have sex with men: a randomized controlled trial. BMC Public Health. 2010;10(1):774. https:\/\/doi.org\/10.1186\/1471-2458-10-774.","journal-title":"BMC Public Health"},{"issue":"2","key":"758_CR23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jsat.2014.03.001","volume":"47","author":"DS Festinger","year":"2014","unstructured":"Festinger DS, Dugosh KL, Kirby KC, Seymour BL. Contingency management for cocaine treatment: cash vs. vouchers. J Subst Abuse Treat. 2014;47(2):168\u201374. https:\/\/doi.org\/10.1016\/j.jsat.2014.03.001.","journal-title":"J Subst Abuse Treat"},{"issue":"11","key":"758_CR24","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1001\/archgenpsychiatry.2011.124","volume":"68","author":"GN Colfax","year":"2011","unstructured":"Colfax GN, Santos GM, Das M, et al. Mirtazapine to reduce methamphetamine use: a randomized controlled trial. Arch Gen Psychiatry. 2011;68(11):1168\u201375. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2011.124.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"758_CR25","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1001\/jamapsychiatry.2019.3655","volume":"77","author":"PO Coffin","year":"2020","unstructured":"Coffin PO, Santos GM, Hern J, et al. Effects of mirtazapine for methamphetamine use disorder among cisgender men and transgender women who have sex with men: a placebo-controlled randomized clinical trial. JAMA Psychiatr. 2020;77(3):246. https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.3655.","journal-title":"JAMA Psychiatr"},{"issue":"2","key":"758_CR26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa2020214","volume":"384","author":"MH Trivedi","year":"2021","unstructured":"Trivedi MH, Walker R, Ling W, et al. Bupropion and naltrexone in methamphetamine use disorder. N Engl J Med. 2021;384(2):140\u201353. https:\/\/doi.org\/10.1056\/NEJMoa2020214.","journal-title":"N Engl J Med"},{"issue":"12","key":"758_CR27","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1007\/s11606-019-05074-8","volume":"34","author":"B Chan","year":"2019","unstructured":"Chan B, Kondo K, Freeman M, Ayers C, Montgomery J, Kansagara D. Pharmacotherapy for cocaine use disorder\u2014a systematic review and meta-analysis. J Gen Intern Med. 2019;34(12):2858\u201373. https:\/\/doi.org\/10.1007\/s11606-019-05074-8.","journal-title":"J Gen Intern Med"},{"key":"758_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2022.208938","volume":"146","author":"JS Tauscher","year":"2023","unstructured":"Tauscher JS, DePue MK, Swank J, Salloum RG. Determinants of preference for telehealth versus in-person treatment for substance use disorders: a discrete choice experiment. J Subst Use Addict Treat. 2023;146:208938. https:\/\/doi.org\/10.1016\/j.josat.2022.208938.","journal-title":"J Subst Use Addict Treat"},{"issue":"0 2","key":"758_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s10461-014-0990-x","volume":"19","author":"BA Moore","year":"2015","unstructured":"Moore BA, Rosen MI, Wang Y, et al. A remotely-delivered CBT and contingency management therapy for substance using people with HIV. AIDS Behav. 2015;19(0 2):156\u201362. https:\/\/doi.org\/10.1007\/s10461-014-0990-x.","journal-title":"AIDS Behav"},{"key":"758_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103872","volume":"109","author":"N Palmateer","year":"2022","unstructured":"Palmateer N, Hamill V, Bergenstrom A, et al. Interventions to prevent HIV and hepatitis C among people who inject drugs: latest evidence of effectiveness from a systematic review (2011 to 2020). Int J Drug Policy. 2022;109:103872. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103872.","journal-title":"Int J Drug Policy"},{"issue":"11","key":"758_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1089\/apc.2023.0170","volume":"37","author":"MF Che Pa","year":"2023","unstructured":"Che Pa MF, Makmor-Bakry M, Islahudin F. Digital health in enhancing antiretroviral therapy adherence: a systematic review and meta-analysis. AIDS Patient Care STDS. 2023;37(11):507\u201316. https:\/\/doi.org\/10.1089\/apc.2023.0170.","journal-title":"AIDS Patient Care STDS"},{"key":"758_CR32","doi-asserted-by":"publisher","unstructured":"Ameri A, Keshvardoost S, Bahaadinbeigy K. Impact of mobile phone-based interventions on methamphetamine use and high-risk sexual behaviors in men who have sex with men (MSM): A systematic review. Addict Healt. 2020;12(1). https:\/\/doi.org\/10.22122\/ahj.v12i1.254.","DOI":"10.22122\/ahj.v12i1.254"},{"issue":"1","key":"758_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-019-0064-8","volume":"4","author":"C Baethge","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA\u2014a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4(1):5. https:\/\/doi.org\/10.1186\/s41073-019-0064-8.","journal-title":"Res Integr Peer Rev"},{"key":"758_CR34","unstructured":"Covidence systematic review software. Published online 2024. www.covidence.org."},{"key":"758_CR35","doi-asserted-by":"publisher","DOI":"10.21037\/mhealth.2019.09.12","volume":"6","author":"SE Brown","year":"2020","unstructured":"Brown SE, Krishnan A, Ranjit YS, Marcus R, Altice FL. Assessing mobile health feasibility and acceptability among HIV-infected cocaine users and their healthcare providers: guidance for implementing an intervention. Mhealth. 2020;6:4. https:\/\/doi.org\/10.21037\/mhealth.2019.09.12.","journal-title":"Mhealth"},{"key":"758_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/1874613601004030105","volume":"4","author":"RS Garfein","year":"2010","unstructured":"Garfein RS, Metzner M, Cuevas J, Bousman CA, Patterson T. Formative assessment of ARM-U: a modular intervention for decreasing risk behaviors among HIV-positive and HIV-negative methamphetamine-using MSM. Open AIDS J. 2010;4:105\u201315. https:\/\/doi.org\/10.2174\/1874613601004030105.","journal-title":"Open AIDS J"},{"issue":"7","key":"758_CR37","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1111\/dar.13739","volume":"42","author":"LM Giang","year":"2023","unstructured":"Giang LM, Trang NT, Thuy DT, et al. Using ADAPT-ITT framework to tailor evidence-based interventions for addressing methamphetamine use among methadone patients in Vietnam. Drug Alcohol Rev. 2023;42(7):1667\u201379. https:\/\/doi.org\/10.1111\/dar.13739.","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"758_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-020-00384-1","volume":"17","author":"EC Pasipanodya","year":"2020","unstructured":"Pasipanodya EC, Kohli M, Fisher CB, Moore DJ, Curtis B. Perceived risks and amelioration of harm in research using mobile technology to support antiretroviral therapy adherence in the context of methamphetamine use: a focus group study among minorities living with HIV. Harm Reduct J. 2020;17(1):41. https:\/\/doi.org\/10.1186\/s12954-020-00384-1.","journal-title":"Harm Reduct J"},{"issue":"8","key":"758_CR39","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1080\/09540121.2019.1622637","volume":"32","author":"P Saberi","year":"2020","unstructured":"Saberi P, Dawson Rose C, Wootton AR, et al. Use of technology for delivery of mental health and substance use services to youth living with HIV: a mixed-methods perspective. AIDS Care. 2020;32(8):931\u20139. https:\/\/doi.org\/10.1080\/09540121.2019.1622637.","journal-title":"AIDS Care"},{"key":"758_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/585143","volume":"2013","author":"DJ Moore","year":"2013","unstructured":"Moore DJ, Montoya JL, Blackstone K, et al. Preliminary evidence for feasibility, use, and acceptability of individualized texting for adherence building for antiretroviral adherence and substance use assessment among HIV-infected methamphetamine users. AIDS Res Treat. 2013;2013:585143. https:\/\/doi.org\/10.1155\/2013\/585143.","journal-title":"AIDS Res Treat"},{"issue":"5","key":"758_CR41","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1177\/00178969241253802","volume":"83","author":"A Cepeda","year":"2024","unstructured":"Cepeda A, Nowotny KM, Frankeberger J, Mora EZ, Natera-Rey G, Valdez A. HIV prevention and crack harm reduction using projection mapping in Mexico City. Health Educ J. 2024;83(5):544\u201359. https:\/\/doi.org\/10.1177\/00178969241253802.","journal-title":"Health Educ J"},{"key":"758_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jsat.2017.09.013","volume":"83","author":"E Aharonovich","year":"2017","unstructured":"Aharonovich E, Stohl M, Cannizzaro D, Hasin D. HealthCall delivered via smartphone to reduce co-occurring drug and alcohol use in HIV-infected adults: a randomized pilot trial. J Subst Abuse Treat. 2017;83:15\u201326. https:\/\/doi.org\/10.1016\/j.jsat.2017.09.013.","journal-title":"J Subst Abuse Treat"},{"key":"758_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jsat.2016.12.009","volume":"74","author":"E Aharonovich","year":"2017","unstructured":"Aharonovich E, Sarvet A, Stohl M, et al. Reducing non-injection drug use in HIV primary care: a randomized trial of brief motivational interviewing, with and without HealthCall, a technology-based enhancement. J Subst Abuse Treat. 2017;74:71\u20139. https:\/\/doi.org\/10.1016\/j.jsat.2016.12.009.","journal-title":"J Subst Abuse Treat"},{"issue":"Suppl 2","key":"758_CR44","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s10461-015-1078-y","volume":"19","author":"C Dawson Rose","year":"2015","unstructured":"Dawson Rose C, Cuca YP, Kamitani E, et al. Using interactive web-based screening, brief intervention and referral to treatment in an urban, safety-net HIV clinic. AIDS Behav. 2015;19(Suppl 2):186\u201393. https:\/\/doi.org\/10.1007\/s10461-015-1078-y.","journal-title":"AIDS Behav"},{"key":"758_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108663","author":"JB Fletcher","year":"2022","unstructured":"Fletcher JB, Reback CJ. Optimizing outpatient treatment outcomes among methamphetamine-using gay and bisexual men through a computerized depression intervention. J Subst Abuse Treat. 2022. https:\/\/doi.org\/10.1016\/j.jsat.2021.108663.","journal-title":"J Subst Abuse Treat"},{"key":"758_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109229","volume":"231","author":"S Glasner","year":"2022","unstructured":"Glasner S, Patrick K, Ybarra M, et al. Promising outcomes from a cognitive behavioral therapy text-messaging intervention targeting drug use, antiretroviral therapy adherence, and HIV risk behaviors among adults living with HIV and substance use disorders. Drug Alcohol Depend. 2022;231:109229. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.109229.","journal-title":"Drug Alcohol Depend"},{"issue":"1\u20133","key":"758_CR47","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.drugalcdep.2010.12.016","volume":"116","author":"KS Ingersoll","year":"2011","unstructured":"Ingersoll KS, Farrell-Carnahan L, Cohen-Filipic J, et al. A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV\u2009+\u2009crack cocaine users. Drug Alcohol Depend. 2011;116(1\u20133):177\u201387. https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.12.016.","journal-title":"Drug Alcohol Depend"},{"key":"758_CR48","doi-asserted-by":"publisher","unstructured":"Moore AA, Lake JE, Glasner S et al. Establishing the feasibility, acceptability and preliminary efficacy of a multi-component behavioral intervention to reduce pain and substance use and improve physical performance in older persons living with HIV. J Substance Abuse Treatment. 2019;100((Moore A.A., alisonmoore@ucsd.edu; Karlamangla A.; Preciado D.; Jenkins J.; Dominguez B.X.; Liao D.H.) Division of Geriatrics, Department of Medicine, University of California, Los Angeles, CA, United States(Lake J.E.) Division of Infectious Diseases, Dep):29\u201338. https:\/\/doi.org\/10.1016\/j.jsat.2019.02.003.","DOI":"10.1016\/j.jsat.2019.02.003"},{"issue":"Suppl 2","key":"758_CR49","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s10461-014-0985-7","volume":"19","author":"CJ Reback","year":"2015","unstructured":"Reback CJ, Fletcher JB, Shoptaw S, Mansergh G. Exposure to theory-driven text messages is associated with HIV risk reduction among methamphetamine-using men who have sex with men. AIDS Behav. 2015;19(Suppl 2):130\u201341. https:\/\/doi.org\/10.1007\/s10461-014-0985-7.","journal-title":"AIDS Behav"},{"issue":"1","key":"758_CR50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10461-018-2225-z","volume":"23","author":"CJ Reback","year":"2019","unstructured":"Reback CJ, Fletcher JB, Swendeman DA, Metzner M. Theory-based text-messaging to reduce methamphetamine use and HIV sexual risk behaviors among men who have sex with men: automated unidirectional delivery outperforms bidirectional peer interactive delivery. AIDS Behav. 2019;23(1):37\u201347. https:\/\/doi.org\/10.1007\/s10461-018-2225-z.","journal-title":"AIDS Behav"},{"key":"758_CR51","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.drugalcdep.2018.05.013","volume":"189","author":"DJ Moore","year":"2018","unstructured":"Moore DJ, Pasipanodya EC, Umlauf A, et al. Individualized texting for adherence building (iTAB) for methamphetamine users living with HIV: a pilot randomized clinical trial. Drug Alcohol Depend. 2018;189:154\u201360. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.05.013.","journal-title":"Drug Alcohol Depend"},{"issue":"513","key":"758_CR52","first-page":"305","volume":"55","author":"S Rubak","year":"2005","unstructured":"Rubak S, Sandbaek A, Lauritzen T, Christensen B. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract. 2005;55(513):305\u201312.","journal-title":"Br J Gen Pract"},{"issue":"7","key":"758_CR53","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s10461-012-0200-7","volume":"16","author":"CJ Reback","year":"2012","unstructured":"Reback CJ, Grant DL, Fletcher JB, et al. Text messaging reduces HIV risk behaviors among methamphetamine-using men who have sex with men. AIDS Behav. 2012;16(7):1993\u20132002. https:\/\/doi.org\/10.1007\/s10461-012-0200-7.","journal-title":"AIDS Behav"},{"issue":"1","key":"758_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-017-0101-1","volume":"12","author":"C Dawson-Rose","year":"2017","unstructured":"Dawson-Rose C, Draughon JE, Cuca Y, et al. Changes in specific substance involvement scores among SBIRT recipients in an HIV primary care setting. Addict Sci Clin Pract. 2017;12(1):34. https:\/\/doi.org\/10.1186\/s13722-017-0101-1.","journal-title":"Addict Sci Clin Pract"},{"issue":"4","key":"758_CR55","doi-asserted-by":"publisher","first-page":"528","DOI":"10.18553\/jmcp.2021.27.4.528","volume":"27","author":"JA Tice","year":"2021","unstructured":"Tice JA, Whittington MD, Campbell JD, Pearson SD. The effectiveness and value of digital health technologies as an adjunct to medication-assisted therapy for opioid use disorder: a summary from the Institute for clinical and economic review\u2019s Midwest comparative effectiveness public advisory council. JMCP. 2021;27(4):528\u201332. https:\/\/doi.org\/10.18553\/jmcp.2021.27.4.528.","journal-title":"JMCP"},{"key":"758_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108926","volume":"144","author":"SK Kiburi","year":"2023","unstructured":"Kiburi SK, Ngarachu E, Tomita A, Paruk S, Chiliza B. Digital interventions for opioid use disorder treatment: a systematic review of randomized controlled trials. J Subst Abuse Treat. 2023;144:108926. https:\/\/doi.org\/10.1016\/j.jsat.2022.108926.","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"758_CR57","doi-asserted-by":"publisher","DOI":"10.2196\/15752","volume":"8","author":"J Nuamah","year":"2020","unstructured":"Nuamah J, Mehta R, Sasangohar F. Technologies for opioid use disorder management: mobile app search and scoping review. JMIR Mhealth Uhealth. 2020;8(6):e15752. https:\/\/doi.org\/10.2196\/15752.","journal-title":"JMIR Mhealth Uhealth"},{"issue":"10","key":"758_CR58","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1111\/acer.15175","volume":"47","author":"I Sohi","year":"2023","unstructured":"Sohi I, Shield KD, Rehm J, Monteiro M. Digital interventions for reducing alcohol use in general populations: an updated systematic review and meta-analysis. Alcohol Clin Exp Res. 2023;47(10):1813\u201332. https:\/\/doi.org\/10.1111\/acer.15175.","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"758_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02374-5","volume":"20","author":"M Bendtsen","year":"2022","unstructured":"Bendtsen M, \u00c5sberg K, McCambridge J. Effectiveness of a digital intervention versus alcohol information for online help-seekers in Sweden: a randomised controlled trial. BMC Med. 2022;20(1):176. https:\/\/doi.org\/10.1186\/s12916-022-02374-5.","journal-title":"BMC Med"},{"key":"758_CR60","unstructured":"Centers for Disease Control and Prevention. HIV Diagnoses, Deaths, and Prevalence. 2025. Accessed September 5, 2025. https:\/\/www.cdc.gov\/hiv-data\/nhss\/hiv-diagnoses-deaths-prevalence.html"},{"issue":"6","key":"758_CR61","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s11121-017-0799-8","volume":"18","author":"ED Storholm","year":"2017","unstructured":"Storholm ED, Volk JE, Marcus JL, Silverberg MJ, Satre DD. Risk perception, sexual behaviors, and PrEP adherence among substance-using men who have sex with men: a qualitative study. Prev Sci. 2017;18(6):737\u201347. https:\/\/doi.org\/10.1007\/s11121-017-0799-8.","journal-title":"Prev Sci"},{"issue":"7","key":"758_CR62","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/QAD.0000000000000613","volume":"29","author":"M Martin","year":"2015","unstructured":"Martin M, Vanichseni S, Suntharasamai P, et al. The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs. AIDS. 2015;29(7):819\u201324. https:\/\/doi.org\/10.1097\/QAD.0000000000000613.","journal-title":"AIDS"},{"issue":"1","key":"758_CR63","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1071\/SH19083","volume":"17","author":"VM McMahan","year":"2020","unstructured":"McMahan VM, Violette LR, Andrasik MP, Martin A, Garske L, Stekler JD. I make sure my doctor doesn\u2019t know that i use meth: perceived barriers to pre-exposure prophylaxis (PrEP) uptake among community peer educators in Seattle (WA, USA). Sex Health. 2020;17(1):29. https:\/\/doi.org\/10.1071\/SH19083.","journal-title":"Sex Health"},{"issue":"7","key":"758_CR64","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s11121-015-0610-7","volume":"17","author":"KG Hill","year":"2016","unstructured":"Hill KG, Woodward D, Woelfel T, Hawkins JD, Green S. Planning for long-term follow-up: strategies learned from longitudinal studies. Prev Sci. 2016;17(7):806\u201318. https:\/\/doi.org\/10.1007\/s11121-015-0610-7.","journal-title":"Prev Sci"},{"issue":"8","key":"758_CR65","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.6019","volume":"1","author":"T Fitzpatrick","year":"2018","unstructured":"Fitzpatrick T, Perrier L, Shakik S, et al. Assessment of long-term follow-up of randomized trial participants by linkage to routinely collected data: a scoping review and analysis. JAMA Netw Open. 2018;1(8):e186019. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.6019.","journal-title":"JAMA Netw Open"},{"key":"758_CR66","unstructured":"United Nations Office on Drugs and Crime. World drug report 2024. Accessed May 14. 2025. https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2024.html"},{"key":"758_CR67","unstructured":"Centers for Disease Control and Prevention. HIV surveillance report, 2019. Centers for disease control and prevention; 2021. https:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html"},{"key":"758_CR68","unstructured":"Barry MP, Meana B, Glick SN et al. Trends and correlates of methamphetamine use among men who have sex with men in the US, 2015\u20132022. In: 2024."},{"key":"758_CR69","unstructured":"Wallerstein N, Duran B, Oetzel J, Minkler M, editors. Community-based participatory research for health: Advancing social and health equity. Third edition. Jossey-Bass & Pfeiffer Imprints, Wiley; 2017."},{"issue":"6","key":"758_CR70","first-page":"702","volume":"106","author":"ME Bailey","year":"1991","unstructured":"Bailey ME. Community-based organizations and CDC as partners in HIV education and prevention. Public Health Rep. 1991;106(6):702\u20138.","journal-title":"Public Health Rep"},{"key":"758_CR71","doi-asserted-by":"publisher","first-page":"004695802211393","DOI":"10.1177\/00469580221139372","volume":"59","author":"S Yasmin","year":"2022","unstructured":"Yasmin S, Haque R, Kadambaya K, Maliha M, Sheikh M. Exploring how public health partnerships with community-Based organizations (CBOs) can be leveraged for health promotion and community health. INQUIRY. 2022;59:004695802211393. https:\/\/doi.org\/10.1177\/00469580221139372.","journal-title":"INQUIRY"},{"key":"758_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108917","volume":"227","author":"JI Tsui","year":"2021","unstructured":"Tsui JI, Leroux BG, Radick AC, et al. Video directly observed therapy for patients receiving office-based buprenorphine \u2013 a pilot randomized controlled trial. Drug Alcohol Depend. 2021;227:108917. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108917.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"758_CR73","doi-asserted-by":"publisher","DOI":"10.2196\/mhealth.4470","volume":"4","author":"BS Linas","year":"2016","unstructured":"Linas BS, Genz A, Westergaard RP, et al. Ecological momentary assessment of illicit drug use compared to biological and self-reported methods. JMIR mHealth uHealth. 2016;4(1):e27. https:\/\/doi.org\/10.2196\/mhealth.4470.","journal-title":"JMIR mHealth uHealth"},{"issue":"1","key":"758_CR74","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/dar.13314","volume":"41","author":"C Getty","year":"2022","unstructured":"Getty C, Weaver T, Lynskey M, Kirby KC, Dallery J, Metrebian N. Patients\u2019 beliefs towards contingency management: target behaviours, incentives and the remote application of these interventions. Drug Alcohol Rev. 2022;41(1):96\u2013105. https:\/\/doi.org\/10.1111\/dar.13314.","journal-title":"Drug Alcohol Rev"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-025-00758-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-025-00758-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-025-00758-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:35:36Z","timestamp":1778646936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11904-025-00758-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["758"],"URL":"https:\/\/doi.org\/10.1007\/s11904-025-00758-9","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"14 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest or financial disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"49"}}